SESSION 10. BENEFIT/RISK EVALUATION OF MEDICINAL PRODUCTS

Benefit-Risk and biosimilar development
November, Thursday 20 | 11:50 - 12:10

Speakers

CATHERINE TCHINOU
SANDOZ - Head Medical Safety Biopharma